DeviceTalks Podcast Network

Hosted by DeviceTalks Podcast Network

TechnologyInterviews guestsExplicit

Website RSS feed LinkedIn Facebook YouTube

Episodes

475

Latest episode

Aug 2026

Language

About the show

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry. Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges. Our Lineup of Shows Includes: • DeviceTalks Weekly • AbbottTalks • Boston Scientific Talks • DeviceTalks AI • IntuitiveTalks • MedtechWOMEN Talks • MedtronicTalks • Neuro Innovation Talks: J&J MedTech Neurovascular • Structural Heart Talks: Edwards Lifesciences • Ortho Innovation Talks: Enovis & Zimmer Biomet • StrykerTalks Why Subscribe? Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered. If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience. Meet Your Hosts: • Tom Salemi, Editorial Director, DeviceTalks • Kayleen Brown, Managing Editor, DeviceTalks #DeviceTalks, Where Device Makers Connect.

Listen to episodes

60 recent

August 21, 20261 hr 1 min

Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage

In this podcast episode, Tito Porras, MD, MBA, CEO and co-founder of startup Inner Logic, shares his unusual path to MedTech entrepreneurship with Host Tom Salemi. Dr. Porras was training to become a neurosurgeon at Johns Hopkins when he began questioning the limits of surgeon training. He realized that even better training wouldn't solve the larger problem: there aren't enough surgeons to provide the care patients need. That realization eventually led Porras to entrepreneurship and Inner Logic, which is developing intelligence and simulation infrastructure that can help develop devices with greater autonomy. Porras explains the difference between automation and autonomy, how AI can help devices perceive and adapt to what's happening during a procedure, and why this technology could eventually expand access to surgical care. Dr. Porras also discusses Inner Logic's work with virtual patients and synthetic data, the potential for autonomy across endovascular, orthopedic and surgical applications, and why the future of autonomous surgery will likely arrive through a series of incremental steps rather than one dramatic leap. MassDevice Editor Chris Newmarker kicks off the podcast with Newmarker's Newsmakers, covering the FDA, Haemonetics, Senseonics, Johnson & Johnson MedTech and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:15) - Trump nominates policy aide as next FDA commissioner (00:09:28) - Haemonetics reconnects with CSL in US plasma collection deal (00:13:22) - Senseonics sees activist investor take a major stake (00:16:08) - Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software (00:17:45) - Medtronic faces potential injunction in Applied Medical case (00:22:26) - Keynote Interview – Tito Porras, MD, CEO and Co-Founder of Inner Logic

August 14, 20261 hr 14 min

Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio

In this episode of DeviceTalks Weekly, Host Tom Salemi welcomes Kendra Grubb, MD, vice president and chief medical officer of Medtronic’s Structural Heart business. Dr. Grubb fulfilled her childhood ambition of becoming a cardiac surgeon and an interventionalist. In this episode, Dr. Grubb discusses how structural heart has transformed over the past two decades and why she believes the field is approaching another major disruption. She explores the future of transcatheter therapies, the growing role of AI, imaging and robotics, the challenge of treating more patients, and how Medtronic is building a broader structural heart portfolio. Dr. Grubb also shares her unusual journey from cardiac surgeon and academic leader to medtech executive and explains why she believes the next generation of structural heart technology must make advanced therapies more accessible to more patients. This episode is sponsored by Cortland Biomedical. Go to https://www.cortlandbiomedical.com/ to see their work in the structural heart space. MassDevice Editor Chris Newmarker delivers this week’s Newmarker’s Newsmakers – Alcon, Intuitive, Cook Medical, CVRx, and GE HealthCare. To register for Medical Design & Outsourcing’s Min-Vasive MedTech Webinar Series, go here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415899/medical-design-outsourcing . *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

August 7, 20261 hr 9 min

How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise

In this episode of the DeviceTalks Weekly podcast, Mobia Medical CEO Richard Foust explains how the “magical” qualities of the company's neurotechnology helped steer it toward an IPO. Mobia Medical’s implantable pulse generator promotes motor skill recovery in patients who have suffered a stroke. The company’s early commercial success has generated modest revenue, but Foust tells host Tom Salemi that “not all revenue is the same,” explaining why a large, untapped and growing market won over venture capital investors a few years ago and public investors this spring. MassDevice Editor Chris Newmarker returns with another edition of Newmarker’s Newsmakers . Tom and Chris repeatedly lament the departure of former Senior Editor Sean Whooley, who recently left MassDevice to pursue other opportunities. Despite his departure, Sean’s reporting remains front and center, as he wrote all five featured stories covering Danaher, Medtronic, Boston Scientific, Integer, Teleflex, and private equity investors. Special thanks to our sponsors of MassDevice’s Diabetes Technology Innovations Special Report: Cadence , Jabil , and Viant Medical ! Download the complimentary report here: https://www.massdevice.com/diabetes-technology-innovations-special-report-2026/ *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

July 31, 20261 hr 12 min

Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller

In this episode of the DeviceTalks Weekly podcast, we tackle a range of topics related to the surgical robotics industry. In our keynote conversation, Brian Miller, formerly of Intuitive and now CEO of Sovato, discusses the potential of telesurgery, a promising capability of surgical robotic systems that could save lives while reducing costs and improving efficiency across the healthcare system. In our FOMO interview, Christy Gaudet, global head of solutions at Karl Storz, explains the company's decision to discontinue the Asensus Surgical robotics systems and focus on the often under-appreciated art of imaging. Finally, surgical robotics expert Steve Bell shares his top five newsmakers from the Society of Robotic Surgery (SRS) Annual Meeting, including Ottava, AI, and humanoid surgical robots. Host Tom Salemi also interviews Jim Leonard, vice president of sales at Harmonic Drive, the sponsor of this episode. Visit http://HarmonicDrive.net for more information. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

July 24, 202640 min

Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi is joined by Harith Rajagopalan, MD, PhD, co-founder and CEO of Fractyl Health. Dr. Rajagopalan explains why Fractyl shifted its focus from treating type 2 diabetes to helping former GLP-1 users maintain their weight loss with Revita, an outpatient endoscopic procedure designed to target the root causes of metabolic disease in the duodenum. He also shares new clinical data, the strategy behind Fractyl's pivotal trial, the company's commercialization plans, and why he believes metabolic endoscopy could become an entirely new category of care. This episode is brought to you by the DeviceTalks Interventional Innovations series, July 28-30th. To register for this complimentary series, click here . *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:35) - Keynote Interview - Harith Rajagopalan, MD, PhD, Co-Founder and Chief Executive Officer, Fractyl Health (00:06:26) - Starting with Back of the Napkin Idea (00:18:45) - Why patients are enthusiastic (00:24:35) - The Parallels to Renal Denervation (00:29:40) - Commercial Plans, Pivotal Trials & What's Next

July 17, 20261 hr 17 min

J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

In this episode of the DeviceTalks Weekly Podcast, Managing Editor Kayleen Brown sits down with Johnson & Johnson MedTech Heart Recovery Worldwide President Devi Govender at DeviceTalks Boston. Govender shares how a deeply personal family experience shaped her mission to transform cardiovascular care. She reflects on Abiomed's integration into Johnson & Johnson, the evolution of heart recovery therapies, and why the industry must shift its mindset from treating "heart failure" to enabling "heart recovery." The discussion explores patient-centered innovation, AI, clinical evidence, and the power of combining technologies, data, and advocacy to redefine the future of cardiovascular care for patients around the world. This episode is sponsored by Freudenberg Medical. Listen for a conversation with Shane Healy, Senior Director of Technology. Visit FreudenbergMedical.com for more information. We'll kick off this episode with Newmarker's Newsmakers. Host Tom Salemi and MassDevice Editor Chris Newmarker revisit the top MedTech stories of the week: Zeta Surgical, Hologic, Medtronic, Fractyl Health, and Vicarious Surgical. --- Enjoy the show? Follow DeviceTalks Weekly on all major podcast platforms, and subscribe to YouTube.com/@DeviceTalks so you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Subscribe today at [https://devicetalks.castos.com/subscribe](https://devicetalks.castos.com/subscribe). Chapters (00:09:10) - Zeta wins FDA clearance for TMS robotic stereotactic system (00:13:01) - Private equity firms reportedly set $4B price on Hologic Surgical unit (00:15:03) - Medtronic, FDA pick up legal victories in spinal cord stimulator suits (00:16:20) - Fractyl Health says its single-catheter treatment maintained most GLP-1 weight loss (00:22:17) - Vicarious Surgical's board wants to shut down and liquidate the robotics developer (00:29:53) - Interview with Shane Healy, Senior Director of Technology, Freudenberg Medical (00:36:53) - Keynote interview with Devi Govender, Worldwide President, Heart Recovery, Johnson & Johnson MedTech

July 10, 20261 hr 10 min

XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

In this episode of DeviceTalks Weekly, Host Tom Salemi explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. Fonseca shares the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday." Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal. To learn more about XCATH and talk with Fonseca, join us on July 29 for a live DeviceTalks discussion. Register here for the free webinar . Thank you to our sponsors Confluent, Jabil, Maxon, Solesis, Viant, and VitalPath. MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:36) - FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes (00:12:50) - Resmed to sell MatrixCare software business to private equity firm for $490M/ GTCR to divest Biosurgery unit of Corza Medical (00:15:58) - Medtronic’s chief sustainability officer is departing (00:17:55) - Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences (00:19:56) - Johnson & Johnson wins FDA approval for ThermoCool SmartTouch dual-energy ablation system

June 26, 20261 hr 15 min

Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal. Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO. Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In this week's FOMO interview, HistoSonics President and CEO Mike Blue speaks with MassDevice Editor Chris Newmarker during a keynote conversation at DeviceTalks Minnesota. In this excerpt, Blue reflects on the company's first major fundraising round, which attracted high-profile investors including Jeff Bezos and Peter Thiel, and shares his perspective on just how large the opportunity for histotripsy could become. But first, Tom and Jim Hammerand, managing editor of Medical Design & Outsourcing, discuss AI—or LLMs, or whatever term you prefer. Is the hype beginning to fade? And what should the industry make of the recent announcement from Midjourney Medical? *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - AI Talk with Jim Hammerand, managing editor, Medical Design & Outsourcing (00:24:46) - DeviceTalks Minnesota interview excerpt - Mike Blue, CEO and President, Histosonics (00:41:44) - Keynote Interview with Joe Catanese, CEO and President, Calyxo

June 19, 20261 hr 1 min

Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing for Recor Medical and Renal Denervation

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi visits his MedTech happy place — renal denervation — with Recor Medical COO Helen Reeve Stoffer. Reeve Stoffer joined the company shortly before the bottom fell out of the renal denervation market in 2014. This interview picks up from that point and follows Recor's pursuit of FDA approval to where denervation technology may be applied next. This week’s FOMO features a portion of a keynote interview with Manny Villafaña, MedTech legend and CEO of Medical 21. The conversation took place at DeviceTalks Minnesota and focuses on the dream that saved St. Jude Medical. Skyler Rivera, associate editor of MassDevice, gives us a preview of her upcoming feature in Medical Design & Outsourcing magazine on the race to provide telesurgery capabilities to surgical robotic systems. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:42) - Associate Editor Skyler Rivera's path the MedTech (and MassDevice) (00:06:00) - MDO covers the race for robotic telesurgery platforms in stroke (00:11:12) - Rivera reviews the race leaders (00:16:30) - FOMO Studio - Manny Villafana, MedTech Legend and CEO of Medical 21 (00:28:19) - Keynote Interview - Helen Reeve Stoffer, COO, Recor Medical

June 12, 20261 hr 2 min

Intuitive's Hutton on Why the Surgical Robotics Leader Is Taking Aim at Cardiac Surgery Again

In this episode, Host Tom Salemi is joined by Darla Hutton, Intuitive’s global vice president of cardiac surgery, to discuss the surgical robotics giant’s return to cardiac surgery. Intuitive famously aimed for the heart at its outset but pivoted when cardiac surgery proved too complicated. Today, heart patients and surgeons are pushing for minimally invasive procedures, and Hutton, a former cardiac surgery OR nurse, has been tapped to lead the company’s push into an increasingly competitive specialty. But first, Harmonic Drive’s Bill Frey, regional sales engineer, joins us in the FOMO Studio. Go to HarmonicDrive.net for more information. Filling in for MassDevice’s Chris Newmarker, Senior Editor Sean Whooley wraps up the five biggest stories to come out of the American Diabetes Association meeting — Abbott, Senseonics, Sequel, Dexcom, and Insulet. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:43) - Abbott studies reinforce DKA opportunity following dual sensor milestone (00:07:13) - Senseonics study supports Eversense 365 CGM with automated insulin delivery tech (00:09:20) - Sequel Med Tech data supports twiist automated insulin delivery in type 2 diabetes (00:11:18) - Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes (00:13:01) - Insulet data backs Omnipod 6, fully closed-loop AID systems (00:16:29) - FOMO Studio - Bill Frey, regional sales engineer, Harmonic Drive (00:27:14) - Keynote Interview - Darla Hutton, Global Vice President, Cardiac Surgery Intuitive